Microneedling Versus Carboxytherapy in Stria Distensae Rubra

Alexandria University

Status

Active, not recruiting

Conditions

Striae Distensae

Treatments

Device: microneedling

Device: Carboxytherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT07001644

0107162

Details and patient eligibility

About

The aim of this study is to evaluate and compare the efficacy and safety of microneedling and carboxytherapy either with or without platelet-rich plasma in the treatment of striae distensae rubra.

Enrollment

50 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Female patients.
Age ranging from 18-45 years old.
Fitzpatrick skin type III-IV.
Striae distensae rubra on the abdomen (bilateral and more or less symmetrical).

Exclusion criteria

Patients taking immunosuppressants or having any disease affecting wound healing including diabetes.
Patients receiving systemic glucocorticoids for chronic health conditions.
Patients with chronic dermatologic diseases such as psoriasis and vitiligo.
Pregnant and lactating females.
Patients with a tendency for keloid formation.
Patients with endocrine disturbance.
Patients with autoimmune diseases, systemic diseases such as severe anemia, respiratory, cardiac, renal or liver disorder.
Patients with bleeding and coagulation disorders.
Patients who received any form of treatment for their SD in the past 6 months.